Bivirkninger rapporteret i forekomsten ≥ 10% i pædiatriske undersøgelser er tidligere rapporteret for voksne (Tabel 4) og er ikke gentaget i den pædiatriske tabel.
Adverse reactions reported at a ≥ 10% incidence in paediatric trials were previously reported in adults (Table 4) and are not repeated in the paediatric table.